Drugs / Bacille Calmette-Guerrin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01373294 | Nov 2011 → Jan 2015 | urinary bladder cancer | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacille Calmette-Guerrin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01373294 ↗ |
| Known as | BCG | “The other drug used in this study is Bacille Calmette-Guerrin (BCG).” NCT01373294 ↗ |
| Modality | Vaccine | “BCG Vaccine” NCT01373294 ↗ |